# Tranexamic Acid in HIp Fracture Surgery (THIF Study)

> **NCT00327106** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 110 (actual)

## Conditions studied

- Hip Fracture

## Interventions

- **DRUG:** Tranexamic acid (Exacyl)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00327106
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2009-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327106, "Tranexamic Acid in HIp Fracture Surgery (THIF Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00327106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*